ACCUITIS

We are focused on the development of innovative disease modifying new drugs to address underserved diseases. Our initial focus was focused on dermatological diseases and through our continuing research we have validated multiple new indications where our- first-in-class compounds offer therapeutic potential... We are dedicated to restoring hope and quality of life to people suffering from diseases with little hope of treatment. We clinical stage pharmaceutical company with multiple compounds in development that were discovered at Emory University. We are a privately-funded company and have received significant support from the Georgia Research Alliance, GRA Venture Fund, and the BioMed Investor Network... We are engaged in the acquisition and development of pharmaceuticals targeting niche, orphan, and underserved disease states.

Also known as: Accuitis, Inc.

Primary location: Clarkesville United States